• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints.

作者信息

Tuma Rabiya S

出版信息

J Natl Cancer Inst. 2006 Sep 20;98(18):1272-4. doi: 10.1093/jnci/djj403.

DOI:10.1093/jnci/djj403
PMID:16985244
Abstract
摘要

相似文献

1
Sometimes size doesn't matter: reevaluating RECIST and tumor response rate endpoints.有时大小并非关键：重新评估RECIST与肿瘤反应率终点指标。
J Natl Cancer Inst. 2006 Sep 20;98(18):1272-4. doi: 10.1093/jnci/djj403.
2
[New guidelines to evaluate the response to treatment "RECIST"].[评估治疗反应的新指南“RECIST”]
Gan To Kagaku Ryoho. 2000 Dec;27(14):2179-84.
3
Endpoints for assessing drug activity in clinical trials.评估临床试验中药物活性的终点指标。
Oncologist. 2008;13 Suppl 2:19-21. doi: 10.1634/theoncologist.13-S2-19.
4
[Development for and clinical trials of molecular targeting drugs].分子靶向药物的研发与临床试验
Gan To Kagaku Ryoho. 2010 May;37(5):822-7.
5
Trend toward noninferiority trials may mean more difficult interpretation of trial results.非劣效性试验的趋势可能意味着试验结果的解读更加困难。
J Natl Cancer Inst. 2007 Dec 5;99(23):1746-8. doi: 10.1093/jnci/djm258. Epub 2007 Nov 27.
6
New criteria for measuring tumor size ease workloads in clinical trials.测量肿瘤大小的新标准减轻了临床试验的工作量。
ONS Connect. 2009 May;24(5):21.
7
Clinical trials referral resource. Clinical trials of MGI-114.临床试验转诊资源。MGI - 114的临床试验。
Oncology (Williston Park). 1999 Feb;13(2):233, 237-8.
8
Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.新型靶向治疗的临床试验：终点指标、试验设计与分析。
Cancer Invest. 2008 Jun;26(5):439-44. doi: 10.1080/07357900801971057.
9
Response and survival in clinical trials.临床试验中的反应与生存情况。
J Clin Oncol. 1986 Jun;4(6):1013. doi: 10.1200/JCO.1986.4.6.1013.
10
Progression-free survival remains debatable endpoint in cancer trials.无进展生存期在癌症试验中仍是一个有争议的终点指标。
J Natl Cancer Inst. 2009 Nov 4;101(21):1439-41. doi: 10.1093/jnci/djp399. Epub 2009 Oct 14.

引用本文的文献

1
RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads.实体瘤疗效评价标准1.1版评估的变异性：双盲双读的系统图像回顾
Insights Imaging. 2024 Aug 7;15(1):199. doi: 10.1186/s13244-024-01774-w.
2
Assessment of Early Response to Lung Cancer Chemotherapy by Semiquantitative Analysis of Dynamic Contrast-Enhanced MRI.动态对比增强 MRI 半定量分析评估肺癌化疗的早期反应。
Dis Markers. 2022 Jul 23;2022:2669281. doi: 10.1155/2022/2669281. eCollection 2022.
3
F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line EGFR-TKIs.
¹⁸F-氟脱氧葡萄糖PET/CT用于一线表皮生长因子受体酪氨酸激酶抑制剂治疗的晚期肺腺癌和表皮生长因子受体突变患者预后的早期预测
Cancers (Basel). 2022 Mar 15;14(6):1507. doi: 10.3390/cancers14061507.
4
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.基于资助的临床研究人员培训实验：AACR/ASCO 临床癌症研究方法研讨会。
Clin Cancer Res. 2021 Oct 15;27(20):5472-5481. doi: 10.1158/1078-0432.CCR-21-1799. Epub 2021 Jul 26.
5
RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?RECIST 1.1与病灶选择：如何处理基线时的模糊情况？
Insights Imaging. 2021 Mar 18;12(1):36. doi: 10.1186/s13244-021-00976-w.
6
Assessment of very early response evaluation with F-FDG-PET/CT predicts survival in erlotinib treated NSCLC patients-A comparison of methods.采用F-FDG-PET/CT评估早期反应预测厄洛替尼治疗的非小细胞肺癌患者的生存——方法比较
Am J Nucl Med Mol Imaging. 2018 Feb 5;8(1):50-61. eCollection 2018.
7
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.动态对比增强磁共振成像和扩散加权磁共振成像预测局部晚期乳腺癌对新辅助治疗反应的Meta分析
J Med Imaging (Bellingham). 2018 Jan;5(1):011011. doi: 10.1117/1.JMI.5.1.011011. Epub 2017 Nov 24.
8
Automatic detection of new tumors and tumor burden evaluation in longitudinal liver CT scan studies.在纵向肝脏 CT 扫描研究中自动检测新肿瘤和肿瘤负担评估。
Int J Comput Assist Radiol Surg. 2017 Nov;12(11):1945-1957. doi: 10.1007/s11548-017-1660-z. Epub 2017 Aug 30.
9
Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.基于三维图像的力学建模用于预测乳腺癌对新辅助治疗的反应
Comput Methods Appl Mech Eng. 2017 Feb 1;314:494-512. doi: 10.1016/j.cma.2016.08.024. Epub 2016 Sep 1.
10
Liver Tumor Segmentation from MR Images Using 3D Fast Marching Algorithm and Single Hidden Layer Feedforward Neural Network.使用三维快速行进算法和单隐藏层前馈神经网络从磁共振图像中进行肝脏肿瘤分割
Biomed Res Int. 2016;2016:3219068. doi: 10.1155/2016/3219068. Epub 2016 Aug 14.